Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the Company has initiated a Phase 2 study of barzolvolimab in atopic dermatitis (AD) and ...
Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the Company has initiated a Phase 2 study of barzolvolimab in atopic dermatitis (AD) and that the study is actively enrolling patients. AD ...
Rep. Brian Mast (R-FL), an outspoken supporter of Israel and one of the most ardent opponents of a two-state solution in the House, is set to become the next chair of the House Foreign Affairs ...